The results indicated that NanoString's Prosigna Breast Cancer Assay can be used to help identify node-positive early-stage breast cancer patients who are at low risk of recurrence.

The circuit included positive nodes and negative nodes—lesions that disrupted these respective nodes either decreased or increased self-reported spiritual beliefs.